Press Release for Q1FY27

03rd August 2026 The General Manager, The Manager, Department of Corporate Services Listing Department Bombay Stock Exchange Ltd (BSE) National Stock Exchange of India Limited, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No. C/1, 'G' Block, Mumbai - 400 001. Bandra - Kurla Complex, Scrip Code - 543308 Mumbai - 400 051. ISIN: INE967H01025 Symbol - KIMS ISIN: INE967H01025 Dear Sir, Sub: Press Release on the unaudited (Standalone & Consolidated) financial results of the Company for the 01st quarter ended 30th June 2026. With reference to the above-stated subject, please find enclosed herewith the Press Release on the unaudited (Standalone & Consolidated) financial results of the Company for the 01st quarter ended 30th June 2026. The same will also be available on the website of the Company at https://www.kimshospitals.com/investors/Disclosures under Regulation 46 of SEBI (LODR) Regulations, 2015/Financial Information/Press Release. We request you to take this on record. Thanking you, Yours truly, For Krishna Institute of Medical Sciences Limited Nagajayanthi J.R Company Secretary & Compliance Officer Enclosed: As above Krishna Institute of Medical Sciences Limited D.No.: 1-8-31/1, Minister Road, Secunderabad - 500 003, Telangana, India Phone: +91 40 4488 5000/4488 5184 | Fax: +91-40-27840980 | kimshospitals.com CIN: L55101TG1973PLC040558 Press Release 3rd Aug 2026, Hyderabad, India The Board of Directors of Krishna Institute of Medical Sciences Limited (KIMS Hospitals) today approved the financial results for the period ending 30th June 2026. A Snapshot of Consolidated Financial and Operational Highlights are as Follows: Q1 FY27 Updates: • Total Revenue of INR 1,196 Cr, a growth of 36.1% on YoY and 10.3% on QoQ basis. • EBITDA of INR 240 Cr, a growth of 20.1 % on YoY and 10.9 % on QoQ basis. • E BITDA margin stood at 20.1% vs. 22.7% in Q1 FY26 and 19.9 % in Q4 FY26. • PAT at INR 37 Cr in Q1 FY27 against INR 85 Cr and INR 33 Cr in Q1 FY26 and Q4 FY26 respectively. • Consolidated EPS for period ended 30th June 2026 of INR 1.04, a degrowth of 47.2% on YoY basis. • Cash and Cash Equivalents (includes Cash, Bank balance, Deposits with maturity less than 12 months and Investment in Mutual funds) of INR 505 Cr as on 30th June 2026. Q1 FY27 Financial Highlights - Consolidated: • Consolidated Revenue from Operations of INR 1,180 Cr, a growth of 35.3% on YoY and 9.8 % on QoQ basis. • Consolidated EBITDA (Pre-INDAS) of INR 222 Cr, there is a growth of 14.6% on YoY and 12.9 % on QoQ basis. • Consolidated EBITDA (Pre-INDAS and excluding Other Income) of INR 206 Cr, a growth of 10.2 % on YoY and a growth of 10% on QoQ basis. Details on the table below: Amt in Crs Consolidated - Quarterly Results Consolidated - yearly Results Particulars Q1 FY27 Q4 FY26 Q1 FY26 QoQ YoY FY 26 FY 25 YoY Total Income 1,195.9 1,084.3 878.7 10.3% 36.1% 3,930.8 3,067.0 Less : Other Income 16.4 9.7 7.1 26.2 31.9 Revenue from Operations 1,179.5 1,074.6 871.6 9.8% 35.3% 3,904.6 3,035.1 28.6% PBT* 56.6 54.8 1 13.7 3.3% -50.2% 333.9 558.1 -40.2% Add : Interest 83.4 68.1 32.6 202.5 9 0.3 Add : Depreciation 100.8 85.0 53.4 283.2 177.2 Less : Exceptional items - - 10.9 - -11.2 1 0.8 Less : Share of profit from associate, net 1.0 2.6 - 2.6 - of tax Reported EBITDA (Incl. other income) as 239.8 2 16.2 1 99.7 10.9% 20.1% 828.2 814.8 1.6% Less : Other Income 16.4 9.7 7.1 26.2 3.2 Less : INDAS 17.7 19.5 5.9 43.6 2 3.9 EBITDA Pre INDAS & Excl.Other Income 205.7 1 87.0 1 86.7 10.0% 10.2% 758.4 759.0 -0.1% EBITDA % to Revenue from Operations 17.4% 17.4% 21.4% 19.4% 25.0% * PBT inclusive of gain on fair valuation of call option, Statutory impact of new Labor Codes and Share of profit from associate. Operational Highlights Consolidated: Q1 FY27 Updates: • ARPOB grew by 9.7% and 0.1% on YoY and QoQ basis respectively. • ARPP grew by 6.8% on YoY and degrow by 3.8% on QoQ basis. Details on the table below: Consolidated - Quarterly Results Consolidated - yearly Results Particulars Q1 FY27 Q4 FY26 Q1 FY26 QoQ YoY FY 26 FY 25 YoY IP Volume 7 2,493 63,595 57,275 14.0% 26.6% 2,46,297 2,13,346 15.4% OP Volume 6,58,617 6,09,724 5,12,399 8.0% 28.5% 23,00,360 18,34,312 25.4% ARPOB (Rs) 47,200 47,132 43,011 0.1% 9.7% 44,644 39,158 14.0% ARPP (Rs) 1,63,573 1,69,983 1,53,094 -3.8% 6.8% 1,59,575 1,43,293 11.4% Glimpses of Clinical achievements during the Q1 – 2027 KIMS Secunderabad • KIMS Secunderabad achieved a rare milestone of completing 10,000 brain tumour surgeries successfully: A rare case of Weber- Christian Disease patient saved without Liver transplant. Weber- Christian disease is a rare autoimmune disorder characterised by inflammation of fatty tissues beneath the skin. A 26-year-old woman suffering from an extremely rare and life- threatening complication caused by Weber-Christian disease was treated and saved without performing a liver transplant because of her other complications. Severe liver involvement in Weber-Christian Disease is highly fatal and has been documented in only a handful of cases globally. The patient was treated with pulse steroids and advanced immune-modulatory therapy. At a critical stage, doctors administered Anakunra, an IL-1 receptor Antagonist which was specially imported from abroad. This marked the first ever reported use of Anakunra in the world to treat Weber- Christian Disease with fulminant Hepatic failure. Specialists from Rheumatology, Hepatology, Liver transplant intensive care and critical care departments treated her successfully and patient was discharged. She leads a normal life now. • Needle-based Cryoablation relieves chronic Testicular pain without surgery: A 51-year-old patient was suffering from severe scrotal pain for over 8 months making normal life difficult. Despite consulting various hospitals and undergoing various treatments, he found no relief. The doctors performed the procedure of Cryoablation therapy by which the pain causing nerves are disabled providing immediate pain relief. KIMS KONDAPUR • A complex life- saving surgery was performed on a two- month infant diagnosed with a rare congenital heart defect known as ARCAPA (Anomalous Right Coronary Artery from the Pulmonary Artery). It is a rare Congenital heart anomaly, seen in approximately 0.25% of cases. The doctors team successfully performed an open- heart surgery on the infant which was highly challenging due to small size of blood vessels, limited physiological reserves and the complexity of maintaining blood circulation and body temperature during the procedure. The infant has recovered well post the surgery. KIMS ICON VIZAG • Pancreatic Abscess treated successfully without surgery: The Pancreas is a highly sensitive organ and complications affecting it can quickly become life- threatening. A 44- year-old patient was suffering from severe abdominal pain for nearly two months. He was initially diagnosed with acute pancreatitis at a local hospital and standard treatment was given. However, his condition worsened over time, leading to formation of a large collection of pus around the pancreas accompanied by persistent fever, pain, vomiting and difficulty in eating. When he was brought to KIMS ICON, the advanced tests revealed a large pancreatic pseudocyst with infection. The doctors performed a minimally invasive drainage procedure. Following the procedure, the patient showed rapid recovery. The success of this case highlights the effectiveness of EUS- guided minimally invasive techniques in managing complex pancreatic conditions without the need for open surgery. KIMS KINGSWAY NAGPUR • KIMS KINGSWAY achieved a remarkable milestone with the successful completion of 100 Kidney transplants strengthening its reputation as a centre of excellence for advanced renal care in Central India. • In a significant medical breakthrough for central India, KIMS KINGSWAY has successfully performed its first allogeneic bone marrow transplant (BMT) on a young child diagnosed with relapse [Showing first 8,000 characters — download PDF for full document]